SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-065019
Filing Date
2020-12-23
Accepted
2020-12-23 16:28:43
Documents
1
Period of Report
2020-12-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4133
  Complete submission text file 0001209191-20-065019.txt   5505
Mailing Address 1301 SECOND AVE., SUITE 4200 SEATTLE WA 98101
Business Address
LASEZKAY GEORGE M (Reporting) CIK: 0001020514 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37783 | Film No.: 201412690

Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations